行情

QGEN

QGEN

快而精医药
NASDAQ

实时行情|Nasdaq Last Sale

40.56
+3.28
+8.80%
盘后: 40.60 +0.04 +0.10% 18:31 11/15 EST
开盘
37.68
昨收
37.28
最高
41.00
最低
37.15
成交量
847.44万
成交额
--
52周最高
41.55
52周最低
25.04
市值
91.86亿
市盈率(TTM)
-316.1341
分时
5日
1月
3月
1年
5年

分析师评级

11位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

QGEN 新闻

  • Medtech Stock With 28% Gain This Week Confirms It's Fielding Buyout Bids
  • Investor's Business Daily.1天前
  • QIAGEN receives several conditional, non-binding indications of interest, and decides to enter into discussions to explore potential strategic alterna-tives
  • ACCESSWIRE.1天前
  • Qiagen exploring sale after indications of interest
  • Reuters.1天前
  • Qiagen shares halted pending news
  • Seeking Alpha - Article.1天前

更多

所属板块

生物技术和医学研究
+1.25%
制药与医学研究
+1.34%

热门股票

名称
价格
涨跌幅

QGEN 简况

QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
展开

Webull提供Qiagen NV的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。